Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-11-08

Clinical Trial Update: Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses [NA]

View source ↗

Summary

A completed clinical trial comparing surface refractive index shifts of Kalifilcon A lenses with other daily disposable contact lenses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biotrue ONEday
  • DAILIES TOTAL 1
  • Kalifilcon A (Kalifilcon A)
  • Precision 1 (senofilcon A)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Habitual Soft Contact Lens Use | NA | Status: COMPLETED | Results posted: 2021-11-08